NUEVOLUTION A/S: Financial statements 2024
CVR: 26029708
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 118,442,000 and a net result of DKK -18,383,000 compared with DKK -36,208,000 the year before. That is an increase of 53.5% compared with the year before. The profit margin was -15.5%. Equity in the 2024 report amounted to DKK 49,739,000. The solvency ratio was 28.6%. The company had 77 employees in the financial year.
- Revenue
- DKK 118,442,000
- Profit/Loss
- DKK -18,383,000
- Equity
- DKK 49,739,000
- Total Assets
- DKK 173,756,000
- Employees
- 77
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 118.4 mio. | - | -18.4 mio. | 49.7 mio. | 77 |
| 2023 | 77.2 mio. | - | -36.2 mio. | 68.1 mio. | 69 |
| 2022 | 68.5 mio. | - | -28.1 mio. | 104.3 mio. | 63 |
| 2021 | 162.3 mio. | - | 63 mio. | 132.4 mio. | 56 |
| 2020 | 37 mio. | - | -33.5 mio. | 69.5 mio. | 54 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 1, 2024, Thomas Franch is registered as director of NUEVOLUTION A/S.
NUEVOLUTION A/S has published its annual report for 2023. Revenue came to DKK 77,164,000, and the net result was DKK -36,208,000.
As of March 25, 2024, Filippo Montano has joined the board of directors of NUEVOLUTION A/S.
As of March 25, 2024, Carsten Bech has left the board of directors of NUEVOLUTION A/S.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The board consists of Tore von Würden Petersen (chair), Jeffrey David Bernd and Omari Clinton Wise. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.